In sum, the effects of gamma-oryzanol as a therapeutic agent to alleviate pathogenesis of endometriosis in rats were investigated by the protein level of ER-α, SF1, SIRT1, HO-1, LC3 and BECN1. The gene discussed is MAP1LC3A; the disease is endometriosis.